EASL clinical practice guidelines: management of hepatocellular carcinoma
Liver cancer is the fifth most common cancer and the second most frequent cause of cancer-
related death globally. Hepatocellular carcinoma represents about 90% of primary liver …
related death globally. Hepatocellular carcinoma represents about 90% of primary liver …
Molecular and histological correlations in liver cancer
Hepatocellular carcinoma (HCC) is a highly heterogeneous cancer, both at the molecular
and histological level. High-throughput sequencing and gene expression profiling have …
and histological level. High-throughput sequencing and gene expression profiling have …
EASL–EORTC clinical practice guidelines: management of hepatocellular carcinoma
European Association For The Study Of … - Journal of …, 2012 - journal-of-hepatology.eu
EASL–EORTC Clinical Practice Guidelines (CPG) on the management of hepatocellular
carcinoma (HCC) define the use of surveillance, diagnosis, and therapeutic strategies …
carcinoma (HCC) define the use of surveillance, diagnosis, and therapeutic strategies …
[BOOK][B] WHO classification of tumours of the digestive system.
FT Bosman, F Carneiro, RH Hruban, ND Theise - 2010 - cabidigitallibrary.org
This book is the third volume of the 4th Edition of the WHO series on histological and genetic
ty** of human tumours. It is an authoritative, concise reference book providing an …
ty** of human tumours. It is an authoritative, concise reference book providing an …
[HTML][HTML] Cost-of-illness studies: concepts, scopes, and methods
C Jo - Clinical and molecular hepatology, 2014 - ncbi.nlm.nih.gov
Liver diseases are one of the main causes of death, and their ever-increasing prevalence is
threatening to cause significant damage both to individuals and society as a whole. This …
threatening to cause significant damage both to individuals and society as a whole. This …
[HTML][HTML] EASL–EORTC clinical practice guidelines: management of hepatocellular carcinoma
EO for Research… - Journal of …, 2012 - Elsevier
EASL–EORTC Clinical Practice Guidelines (CPG) on the management of hepatocellular
carcinoma (HCC) define the use of surveillance, diagnosis, and therapeutic strategies …
carcinoma (HCC) define the use of surveillance, diagnosis, and therapeutic strategies …
The biology of Hepatocellular carcinoma: implications for genomic and immune therapies
Hepatocellular carcinoma (HCC), the most common type of primary liver cancer, is a leading
cause of cancer-related death worldwide. It is highly refractory to most systemic therapies …
cause of cancer-related death worldwide. It is highly refractory to most systemic therapies …
[PDF][PDF] Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma
A Forner, R Vilana, C Ayuso, L Bianchi, M Solé… - …, 2008 - Wiley Online Library
This study prospectively evaluates the accuracy of contrast‐enhanced ultrasound (CEUS)
and dynamic magnetic resonance imaging (MRI) for the diagnosis of nodules 20 mm or …
and dynamic magnetic resonance imaging (MRI) for the diagnosis of nodules 20 mm or …
Combined hepatocellular-cholangiocarcinoma: an update
A Beaufrère, J Calderaro, V Paradis - Journal of hepatology, 2021 - Elsevier
Combined hepatocellular-cholangiocarcinoma (cHCC-CCA) is a tumour that exhibits both
hepatocytic and biliary differentiation. Classical risk factors for hepatocellular carcinoma …
hepatocytic and biliary differentiation. Classical risk factors for hepatocellular carcinoma …
[PDF][PDF] International Liver Cancer Association (ILCA) white paper on biomarker development for hepatocellular carcinoma
International Liver Cancer Association (ILCA) White Paper on Biomarker Development for
Hepatocellular Carcinoma Page 1 1 International Liver Cancer Association (ILCA) White Paper …
Hepatocellular Carcinoma Page 1 1 International Liver Cancer Association (ILCA) White Paper …